Question 1

Is acute myeloid leukemia treatment possible without transplant?

Accepted Answer

Yes, for favorable-risk AML or elderly patients unfit for transplant, chemotherapy with or without targeted therapy can achieve remission.

Question 2

What is the AML transplant success rate?

Accepted Answer

With matched donors and early transplant during first remission, success rates range between 50%–70% depending on age, risk factors, and MRD status.

Question 3

How long does acute myeloid leukemia (AML) treatment take?

Accepted Answer

Induction chemotherapy usually takes 4–6 weeks. Consolidation or transplant requires another 4–8 weeks. Post-transplant recovery may last several months.

Question 4

How is acute myeloid leukemia (AML) different from chronic myeloid leukemia (CML)?

Accepted Answer

AML is acute and aggressive, requiring immediate intensive therapy. CML is a chronic disease often managed long-term with oral targeted drugs like imatinib

Question 5

What is acute myeloid leukemia (AML) remission treatment?

Accepted Answer

It includes post-chemotherapy or post-transplant follow-up, MRD monitoring, immunosuppression tapering, and infection prevention to avoid relapse.

Question 6

Is acute myeloid leukemia (AML) common in India?

Accepted Answer

Yes, AML is one of the most common acute leukemias in adults, and its incidence is rising in urban populations.

Question 7

Can children get AML?

Accepted Answer

Yes. AML in children and adolescents requires pediatric-specific treatment protocols and is managed by our expert pediatric oncology team.

Useful Links

Work Hours

Call us

Email